Capricor Therapeutics
CAPR
#7980
Rank
$0.29 B
Marketcap
$6.36
Share price
-4.36%
Change (1 day)
-57.82%
Change (1 year)

Capricor Therapeutics (CAPR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : $42.57 Million USD

According to Capricor Therapeutics 's latest financial reports the company's total liabilities are $42.57 Million USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Capricor Therapeutics - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31$25.01 M-30.76%
2023-12-31$36.13 M-5.68%
2022-12-31$38.3 M284.54%
2021-12-31$9.96 M55.2%
2020-12-31$6.41 M50.18%
2019-12-31$4.27 M-7.71%
2018-12-31$4.63 M-8.23%
2017-12-31$5.04 M-77.82%
2016-12-31$22.75 M33.03%
2015-12-31$17.1 M-13.98%
2014-12-31$19.88 M227.38%
2013-12-31$6.07 M1047.61%
2012-12-31$0.52 M-2.27%
2011-12-31$0.54 M-49.35%
2010-12-31$1.06 M67.69%
2009-12-31$0.63 M-52.13%
2008-12-31$1.33 M-29.51%
2007-12-31$1.88 M1301.86%
2006-12-31$0.13 M73%
2005-12-31$0.07 M31.16%
2004-12-31$0.05 M42.22%
2003-12-31$0.04 M70.09%
2002-12-31$0.02 M167.33%
2001-12-31$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Cytokinetics
CYTK
$1.95 B 4,498.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
$10.11 M-76.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$113.53 B 266,605.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
$1.26 B 2,864.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
$50.07 M 17.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
$2.6 M-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA